Koen J. Hartemink

5.5k total citations · 2 hit papers
98 papers, 2.6k citations indexed

About

Koen J. Hartemink is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Koen J. Hartemink has authored 98 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 27 papers in Surgery. Recurrent topics in Koen J. Hartemink's work include Lung Cancer Diagnosis and Treatment (30 papers), Lung Cancer Treatments and Mutations (24 papers) and Radiomics and Machine Learning in Medical Imaging (11 papers). Koen J. Hartemink is often cited by papers focused on Lung Cancer Diagnosis and Treatment (30 papers), Lung Cancer Treatments and Mutations (24 papers) and Radiomics and Machine Learning in Medical Imaging (11 papers). Koen J. Hartemink collaborates with scholars based in Netherlands, United States and United Kingdom. Koen J. Hartemink's co-authors include Egbert F. Smit, Marinus A. Paul, Kim Monkhorst, John B.A.G. Haanen, Fumio Nomura, T Nakayama, K Ohnishi, Christian U. Blank, Ferry Lalezari and Armand R. J. Girbes and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

Koen J. Hartemink

93 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers

2019 372 citations Doenja M. J. Lambregts, Koen J. Hartemink et al. profile →
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer

2021 195 citations Koen J. Hartemink, Kim Monkhorst et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koen J. Hartemink Netherlands	25	1.1k	786	478	475	441	98	2.6k
Erich Stoelben Germany	26	1.6k 1.4×	602 0.8×	548 1.1×	319 0.7×	177 0.4×	147	2.6k
Patricia M. de Groot United States	23	1.2k 1.0×	1.1k 1.4×	312 0.7×	465 1.0×	212 0.5×	54	2.6k
Hooman Yarmohammadi United States	25	469 0.4×	607 0.8×	449 0.9×	333 0.7×	382 0.9×	135	2.1k
Shigetoshi Yoshida Japan	33	1.9k 1.6×	586 0.7×	848 1.8×	190 0.4×	250 0.6×	132	3.1k
Fumihiro Shoji Japan	33	1.6k 1.4×	1.7k 2.2×	446 0.9×	381 0.8×	201 0.5×	150	3.2k
Richard J. Battafarano United States	30	1.4k 1.2×	682 0.9×	670 1.4×	302 0.6×	307 0.7×	70	2.4k
Dietmar Tamandl Austria	34	968 0.8×	1.8k 2.2×	1.4k 2.9×	357 0.8×	586 1.3×	110	4.0k
Yoshifumi Sano Japan	30	2.2k 1.9×	540 0.7×	1.2k 2.5×	226 0.5×	140 0.3×	165	3.6k
Jin‐Sook Ryu South Korea	35	1.1k 0.9×	765 1.0×	1.4k 2.9×	1.2k 2.5×	567 1.3×	208	4.2k
Ladislav Pecen Czechia	26	713 0.6×	555 0.7×	424 0.9×	179 0.4×	273 0.6×	132	2.5k

Countries citing papers authored by Koen J. Hartemink

Since Specialization

Citations

This map shows the geographic impact of Koen J. Hartemink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen J. Hartemink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen J. Hartemink more than expected).

Fields of papers citing papers by Koen J. Hartemink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen J. Hartemink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen J. Hartemink. The network helps show where Koen J. Hartemink may publish in the future.

Co-authorship network of co-authors of Koen J. Hartemink

This figure shows the co-authorship network connecting the top 25 collaborators of Koen J. Hartemink. A scholar is included among the top collaborators of Koen J. Hartemink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen J. Hartemink. Koen J. Hartemink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Christopher G., Koen J. Hartemink, Robert C. Rintoul, et al.. (2025). Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study. PLoS Medicine. 22(4). e1004574–e1004574. 2 indexed citations

Langen, Adrianus J. de, Kim Monkhorst, Houke M. Klomp, et al.. (2024). Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer. Acta chirurgica Belgica. 124(5). 387–395. 1 indexed citations

Dumoulin, Daphne W., Koen J. Hartemink, Monique Hochstenbag, et al.. (2024). The DETECTION project part 1: An international Delphi survey about diagnostics and treatment of anterior mediastinal cystic lesions. Lung Cancer. 199. 108055–108055.

Cattaneo, Chiara M., Thomas Battaglia, Jos Urbanus, et al.. (2023). Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens. Nature Biotechnology. 41(6). 783–787. 27 indexed citations

Sandick, Johanna W. van, Jolanda M. van Dieren, Marieke A. Vollebergh, et al.. (2023). The clinical impact of testing for biomarkers in gastric cancer patients: a real‐world cohort. Histopathology. 82(6). 826–836. 4 indexed citations

Groot, Rosa de, Aurélie Guislain, Kim Monkhorst, et al.. (2022). Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments. Immuno-Oncology Technology. 15. 100090–100090. 4 indexed citations

Boer, Jan Paul de, Menno R. Vriens, Rachel S. van Leeuwaarde, et al.. (2021). Retrospective Analyses of ¹⁸ FDG-PET/CT Thyroid Incidentaloma in Adults: Incidence, Treatment, and Outcome in a Tertiary Cancer Referral Center. Thyroid. 31(11). 1715–1722. 5 indexed citations

Koemans, Willem J., Rosa T. van der Kaaij, Emma C. E. Wassenaar, et al.. (2021). Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial. Journal of Surgical Oncology. 123(4). 904–910. 14 indexed citations

Hartemink, Koen J., Ad F. T. M. Verhagen, Willem H. Steup, et al.. (2021). Variation in incidence, prevention and treatment of persistent air leak after lung cancer surgery. European Journal of Cardio-Thoracic Surgery. 61(1). 110–117. 17 indexed citations

10.

Dickhoff, Chris, Vincent van der Noort, Houke M. Klomp, et al.. (2020). Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?. Lung Cancer. 150. 209–215. 3 indexed citations

11.

Dieren, Jolanda M. van, Francine E.M. Voncken, Sietze T. van Turenhout, et al.. (2020). Added value of MRI to endoscopic and endosonographic response assessment after neoadjuvant chemoradiotherapy in oesophageal cancer. European Radiology. 30(5). 2425–2434. 9 indexed citations

12.

Kaaij, Rosa T. van der, Emma C. E. Wassenaar, Willem J. Koemans, et al.. (2020). Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results. British journal of surgery. 107(11). 1520–1528. 35 indexed citations

13.

Voncken, Francine E.M., Jolanda M. van Dieren, Doenja M. J. Lambregts, et al.. (2019). Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer. British journal of surgery. 106(5). 596–605. 23 indexed citations

14.

Berg, Marloes van den, Pleuni E. Hooijman, Albertus Beishuizen, et al.. (2017). Diaphragm Atrophy and Weakness in the Absence of Mitochondrial Dysfunction in the Critically Ill. American Journal of Respiratory and Critical Care Medicine. 196(12). 1544–1558. 56 indexed citations

15.

Kwint, Margriet, Iris Walraven, Sjaak Burgers, et al.. (2017). Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases. Lung Cancer. 112. 134–139. 30 indexed citations

16.

Szulcek, Robert, Chris Happé, Nina Rol, et al.. (2016). Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension: Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage. American Journal of Respiratory and Critical Care Medicine. 193(12). 1410–1420. 73 indexed citations

17.

Hooijman, Pleuni E., Albertus Beishuizen, Christian Witt, et al.. (2015). Diaphragm Muscle Fiber Weakness and Ubiquitin–Proteasome Activation in Critically Ill Patients. American Journal of Respiratory and Critical Care Medicine. 191(10). 1126–1138. 150 indexed citations

18.

Vos, Cornelis G., Max Dahele, John R. van Sörnsen de Koste, et al.. (2013). Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors. Strahlentherapie und Onkologie. 190(2). 204–209. 4 indexed citations

19.

Gorter, Ramon R., et al.. (2012). Evaluation of arm function and quality of life after trimodality treatment for superior sulcus tumours. Interactive Cardiovascular and Thoracic Surgery. 16(1). 44–48. 5 indexed citations

20.

Oor, Jelmer E., Johannes M. A. Daniels, Pieter E. Postmus, et al.. (2011). Surgical treatment of pulmonary aspergilloma. European Respiratory Journal. 38(Suppl 55). 4699–4699. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact